The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice
作者： Brian Dean
DOI: 10.1046/J.1471-4159.2003.01693.X
关键词:
摘要: … in the hippocampus, brainstem and midbrain whereas sulpride only caused this effect in the … expression or an increase in the rate of degradation rather than the presence of a particular …
sci-hub.se 参考文章(92)
de Paulis T, M-100907 (Aventis). Current opinion in investigational drugs. ,vol. 2, pp. 123- ,(2001)
Lack of Association Between Polymorphisms in the 5-HT2A Receptor Gene and the Antipsychotic Response to Clozapine American Journal of Psychiatry. ,vol. 153, pp. 1092- 1094 ,(1996) , 10.1176/AJP.153.8.1092
A P Pathiraja, R C Meibach, R L Borison, B I Diamond, RISPERIDONE : CLINICAL SAFETY AND EFFICACY IN SCHIZOPHRENIA Psychopharmacology Bulletin. ,vol. 28, pp. 213- 218 ,(1992)
Brian Dean, Tabasum Hussain, Wendy Hayes, Elizabeth Scarr, Susie Kitsoulis, Christine Hill, Kenneth Opeskin, David L. Copolov, Changes in serotonin(2A) and GABA(A) receptors in schizophrenia: Studies on the human dorsolateral prefrontal cortex Journal of Neurochemistry. ,vol. 72, pp. 1593- 1599 ,(1999) , 10.1046/J.1471-4159.1999.721593.X
Graham V. Williams, Srinivas G. Rao, Patricia S. Goldman-Rakic, The Physiological Role of 5-HT2A Receptors in Working Memory The Journal of Neuroscience. ,vol. 22, pp. 2843- 2854 ,(2002) , 10.1523/JNEUROSCI.22-07-02843.2002
Camilla Lundkvist, Lars Farde, Svante Nyberg, Christer Halldin, Hiroshi Ito, PET Imaging of Central 5-HT2A Receptors with Carbon-11-MDL 100,907 The Journal of Nuclear Medicine. ,vol. 39, pp. 208- 214 ,(1998)
Alexander P Kouzmenko, Wendy L Hayes, Avril M Pereira, Brian Dean, Phillip WJ Burnet, Paul J Harrison, 5-HT2A receptor polymorphism and steady state receptor expression in schizophrenia. The Lancet. ,vol. 349, pp. 1815- 1815 ,(1997) , 10.1016/S0140-6736(05)61695-9
Sharon L. Eastwood, Philip W.J. Burnet, Rebecca Gittins, Kate Baker, Paul J. Harrison, Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia. Synapse. ,vol. 42, pp. 104- 114 ,(2001) , 10.1002/SYN.1106
M.M. Nöthen, M. Rietschel, J. Erdmann, H. Oberländer, H-J. Möller, D. Naber, P. Propping, PhilipW.J. Burnet, PaulJ. Harrison, Genetic variation of the 5-HT2A receptor and response to clozapine The Lancet. ,vol. 346, pp. 908- 909 ,(1995) , 10.1016/S0140-6736(95)92756-5
J. H. GADDUM, KHAN A. HAMEED, Drugs which antagonize 5-hydroxytryptamine. British journal of pharmacology and chemotherapy. ,vol. 9, pp. 240- 248 ,(1954) , 10.1111/J.1476-5381.1954.TB00848.X